[144] Huntington Ingalls Industries, Inc. SEC Filing
Rhea-AI Filing Summary
Huntington Ingalls Industries, Inc. (HII) filed a Form 144 indicating an insider’s intent to sell up to 1,000 common shares through Fidelity Brokerage Services on the NYSE around 08/05/2025. The shares have an aggregate market value of $268,627.56, based on the filing’s reference price. With 39,240,631 shares outstanding, the proposed sale represents roughly 0.003 % of HII’s equity—an immaterial amount in terms of float and daily trading volume.
The securities were originally acquired via a series of restricted-stock vestings between 2017-2018. No sales have been made by the filer in the past three months, and the signer certifies no undisclosed adverse information. The Form 144 is a routine disclosure, suggesting personal portfolio management rather than a strategic shift by the company.
Positive
- None.
Negative
- None.
Insights
TL;DR: Minor insider sale—1,000 HII shares (~$269k); negligible 0.003 % of float; neutral corporate impact.
The filing simply notifies regulators of a prospective sale permitted under Rule 144. The transaction is small relative to HII’s market capitalization and daily liquidity, limiting any valuation effect. Shares were earned via compensation grants, a common practice among executives. Lack of recent sales and certification of no undisclosed adverse information suggest routine diversification rather than negative signaling. Overall, I view the disclosure as non-impactful to the investment thesis.